How artificial intelligence could transform medicine from a system that treats illness into one designed to keep people well.
For most people, healthcare begins when something goes wrong.
A pain won’t disappear. A blood test comes back abnormal. A lump appears. Fatigue becomes impossible to ignore. Eventually, an appointment is scheduled.
Then medicine begins searching for an answer.
This system has produced extraordinary achievements. Modern medicine can replace joints, transplant hearts, eradicate infections and increasingly turn once-fatal cancers into manageable diseases.
But there is something fundamentally strange about the architecture.
We are remarkably sophisticated at treating disease after it appears and surprisingly primitive at continuously understanding why an individual is becoming unhealthy in the first place.
Artificial intelligence could begin changing that.
The most consequential application of AI in healthcare may not be replacing doctors or creating a chatbot that diagnoses a sore throat.
It may be transforming healthcare from a periodic, reactive service into something closer to continuous health intelligence.
A system that knows what healthy looks like for you.
Not the average person.
You.
And notices when that trajectory begins changing.
Medicine Has a Data Problem
Imagine visiting a physician once a year.
Your doctor might see your current medications, recent bloodwork, previous diagnoses and perhaps notes from earlier appointments.
But your body has been producing information every second since the previous visit.
Sleep changed.
Heart rate changed.
Exercise changed.
Weight changed.
Nutrition changed.
Stress changed.
Hormones changed.
Thousands of biomarkers moved.
Your environment changed.
New medical studies were published.
Your doctor may have 20 minutes to put the puzzle together.
The problem isn’t necessarily a lack of intelligence or compassion.
It is a problem of human bandwidth.
No physician can continuously read every relevant medical paper while simultaneously analyzing years of laboratory tests, imaging, genetics, medications, symptoms, wearable measurements and medical records for thousands of patients.
Computers can.
That doesn’t make them doctors.
It makes them potentially extraordinary tools for doctors.
And companies are beginning to build the pieces.
What If We Found Disease Before We Felt It?
One of medicine’s greatest advantages is time.
Cancer discovered early is often very different from cancer discovered after it spreads.
Cardiovascular disease identified decades before a heart attack creates opportunities that do not exist during an emergency.
Metabolic dysfunction detected while it is developing may be easier to address than diabetes diagnosed years later.
AI could dramatically expand our ability to recognize these patterns.
Freenome, for example, is combining machine learning and molecular signals in the blood to detect cancer.
In July, the FDA approved Freenome’s SimpleScreen CRC blood test for colorectal cancer screening in average-risk adults 45 and older. Instead of requiring an invasive procedure as the first screening step, the test can begin with an ordinary blood draw.
The technology isn’t perfect, and blood tests do not eliminate the need for traditional diagnostic procedures.
But the direction is important.
Testing becomes easier.
Easier testing potentially means more testing.
More testing can mean earlier detection.
Tempus AI is attacking another part of the problem.
The company has accumulated enormous quantities of clinical and molecular data and is using artificial intelligence to help physicians understand cancers at increasingly detailed levels. Tempus says its models now draw from more than 45 million de-identified patient journeys and over 500 petabytes of molecularly grounded data.
Its PRISM2 pathology model, developed with Microsoft researchers, was recently reported in Nature Medicine to perform a range of diagnostic, biomarker and prognostic tasks from pathology images.
This points toward a different future for diagnosis.
Rather than asking:
“Which disease does this patient appear to have?”
Medicine can increasingly ask:
“What does everything we know about this particular human suggest is beginning to happen?”
That is a much more powerful question.
The Doctor Doesn’t Disappear
Predictions that AI will simply replace doctors miss something essential about medicine.
Healthcare isn’t only an information problem.
A frightened person wants another human being.
Someone has to exercise judgment.
Someone has to understand context.
Someone has to take responsibility for decisions where the answer isn’t obvious.
Someone has to tell a family difficult news.
Medicine is deeply human.
The better vision is not removing the physician.
It is removing everything that prevents the physician from being a physician.
Consider Abridge.
Its AI can listen to a conversation between a doctor and patient and automatically generate clinical documentation. At UCHealth, the system expanded to more than 2,300 providers following a pilot intended partly to reduce documentation work and allow clinicians to focus more directly on patients.
Abridge is now expanding beyond note-taking into contextual clinical intelligence that can work alongside a patient’s medical record and clinical evidence.
The significance isn’t that artificial intelligence can write a medical note.
It is that a doctor might eventually spend less time staring at a computer and more time looking at the person sitting across the room.
The most humane use of AI may be giving humans back to one another.
Charlotte Is Already Becoming Part of This Experiment
This future isn’t limited to Silicon Valley.
It is beginning to appear here.
In June, Novant Health launched an AI-enabled virtual assistant called Aubrey. Its first patient-facing pilot is focused partly on surgical patients in the Charlotte region, providing personalized preparation information, reminders and support around the clock.
Atrium Health is already using AI-supported documentation and virtual-assistant technologies in patient care.
More interestingly, Atrium recently received an $815,000 grant from The Duke Endowment to test generative AI that helps cancer teams interpret complex genomic information. One goal is to extend expertise traditionally concentrated in sophisticated molecular tumor boards to clinicians and patients in rural communities across the Carolinas.
That captures another enormous promise of artificial intelligence:
expertise can become more abundant.
A patient shouldn’t receive dramatically worse information simply because the world’s leading specialist happens to practice hundreds of miles away.
AI cannot manufacture more elite oncologists.
But it can potentially distribute portions of their accumulated knowledge to thousands of clinicians.
Charlotte may be unusually well positioned to participate in this transition.
The Pearl, the city’s new medical innovation district anchored by Wake Forest University School of Medicine and Atrium Health, opened in 2025 with research, medical education and advanced surgical technology concentrated in one campus. Its IRCAD North America center includes work involving robotics, augmented reality and surgical artificial intelligence.
By July 2026, Atrium reported that The Pearl had already generated more than $220 million in regional economic impact.
Charlotte has spent decades becoming a banking center.
It is worth asking whether its next economic identity could include becoming a center for AI-enabled medicine and human health.
Then AI Moves From Diagnosing Disease to Discovering Treatments
There is an even more profound possibility.
What happens when artificial intelligence doesn’t merely recognize disease?
What happens when it helps invent the medicine?
Traditional drug development involves enormous amounts of trial and error.
Scientists identify a biological target.
They search for molecules that affect it.
Candidates are tested.
Most fail.
Others are redesigned.
Years can pass before a treatment ever reaches a patient.
AI companies are attempting to compress parts of that process.
Recursion Pharmaceuticals builds enormous experimental biological datasets and trains computational models to search for patterns humans might never identify manually.
This August, Genentech advanced the first neuroscience target discovered through its collaboration with Recursion into an early drug-discovery program. According to the companies, the target emerged from an AI-driven map of biology and involved previously unexplored neuroscience biology.
Then there is Isomorphic Labs, spun out of the work behind Google DeepMind’s AlphaFold.
The company is attempting to build an AI-first drug-design engine capable of reasoning about biological structures and designing potential medicines computationally.
Investors committed another $2.1 billion to the company in May to expand that platform and advance its therapeutic pipeline.
None of this means drug discovery has suddenly been solved.
Biology has an inconvenient habit of humbling beautiful computer models.
Ultimately, drugs still have to work safely in human beings.
But even modest improvements in the rate at which scientists identify promising targets and eliminate bad candidates could compound dramatically.
Imagine compressing ten years of unsuccessful exploration into five.
Then three.
Now apply that acceleration across cancer, Alzheimer’s disease, autoimmune disorders, rare diseases and thousands of conditions that currently have inadequate treatments.
That could become one of AI’s greatest contributions to civilization.
The Personal Health Intelligence Layer
Now connect these technologies.
One company analyzes your genetics.
Another analyzes pathology.
Another examines medical imaging.
Your smartwatch measures sleep and cardiovascular signals.
Laboratories measure hundreds of biomarkers.
Your medical record contains decades of diagnoses, prescriptions and physician notes.
AI systems continuously read the world’s medical literature.
Drug-discovery models search for new treatments.
Today these exist largely as disconnected islands.
The larger opportunity is to connect them.
Imagine having a secure personal health intelligence system that follows you throughout life.
It understands your baseline.
It knows that your blood glucose has slowly risen for four years even though every individual test remained technically inside the normal range.
It notices that your sleep deteriorates whenever another physiological marker changes.
It sees something subtle in an image that deserves a second look.
It knows your family history.
It knows which medications you take.
It compares new findings against medical literature published yesterday.
But critically, it doesn’t bombard you with hundreds of abnormalities.
It determines what actually matters.
Then it works with qualified clinicians to answer:
What is the highest-value action this person should take next?
That is very different from today’s fragmented experience of healthcare.
You wouldn’t simply have a medical record.
You would have an evolving model of your health.
There Is a Dangerous Version of This Future Too
More measurement does not automatically create better health.
There is a dystopian version of AI medicine where people become obsessed with every fluctuation in every biomarker.
Algorithms generate endless false alarms.
Healthy people are turned into anxious patients.
Insurance companies misuse health predictions.
Sensitive biological information leaks.
Commercial incentives encourage unnecessary testing and treatment.
And patients begin trusting confident algorithms that are sometimes confidently wrong.
That would not represent progress.
A better healthcare system should not make people spend their lives thinking about healthcare.
It should give them more life.
More energy.
More time.
Less suffering.
More years with their children.
Greater ability to work, create, travel, serve others and enjoy being alive.
The objective shouldn’t be maximizing the amount of health data generated.
It should be maximizing human flourishing.
That distinction matters enormously.
From Sick Care to Health Care
The great healthcare institutions of the 20th century were built around places.
Hospitals.
Clinics.
Laboratories.
Pharmacies.
The healthcare system of the 21st century may increasingly be built around intelligence.
Intelligence that is always available.
Intelligence that remembers.
Intelligence capable of examining patterns across millions of patients while still understanding the history of one.
Intelligence that helps a rural physician access knowledge previously available only at elite medical centers.
Intelligence that helps scientists search biological possibilities humans don’t have enough lifetimes to explore manually.
And intelligence that allows doctors to spend less time entering information and more time caring for people.
The ultimate promise of artificial intelligence in healthcare is therefore much larger than automating medicine as it exists today.
It is an opportunity to reconsider what medicine should be.
For generations, we have built extraordinary systems for helping people after they become sick.
Perhaps the next great achievement is building one that becomes equally extraordinary at keeping them well.
Because the purpose of medicine was never the appointment.
It was never the hospital.
It was never the test.
The purpose was always the person.
And the greatest measure of medical progress isn’t how much healthcare we consume.
It is how much healthy life we get to live.
